Literature DB >> 29933877

Magnetic Resonance Imaging for Target Delineation and Daily Treatment Modification.

Rojano Kashani1, Jeffrey R Olsen2.   

Abstract

Magnetic resonance (MR) imaging has become a prevalent modality in radiation oncology owing to its excellent soft-tissue contrast and ability to provide functional information. Recent technological developments have combined MR imaging with treatment delivery systems, to provide in-room MR guidance for patient setup and treatment delivery. Availability of in-room MR imaging enables direct visualization of soft-tissue targets and nearby organs at risk, thus providing a platform for fast and accurate target and organs at risk delineation for plan adaptation and target tracking during treatment. This article describes the 2 clinically implemented MR image-guided radiotherapy systems and their role in target localization and in-room treatment adaptation. Clinical data from early adopters of these systems is reviewed.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 29933877     DOI: 10.1016/j.semradonc.2018.02.002

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  10 in total

Review 1.  Proton beam therapy for tumors of the upper abdomen.

Authors:  Ann Raldow; James Lamb; Theodore Hong
Journal:  Br J Radiol       Date:  2019-08-23       Impact factor: 3.039

Review 2.  A narrative review of MRI acquisition for MR-guided-radiotherapy in prostate cancer.

Authors:  Jing Yuan; Darren M C Poon; Gladys Lo; Oi Lei Wong; Kin Yin Cheung; Siu Ki Yu
Journal:  Quant Imaging Med Surg       Date:  2022-02

3.  First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany.

Authors:  Sebastian Klüter; Sonja Katayama; C Katharina Spindeldreier; Stefan A Koerber; Gerald Major; Markus Alber; Sati Akbaba; Jürgen Debus; Juliane Hörner-Rieber
Journal:  Strahlenther Onkol       Date:  2020-01-30       Impact factor: 3.621

Review 4.  "Après Mois, Le Déluge": Preparing for the Coming Data Flood in the MRI-Guided Radiotherapy Era.

Authors:  Kendall J Kiser; Benjamin D Smith; Jihong Wang; Clifton D Fuller
Journal:  Front Oncol       Date:  2019-09-30       Impact factor: 6.244

5.  Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer.

Authors:  Shyama U Tetar; Anna M E Bruynzeel; Frank J Lagerwaard; Ben J Slotman; Omar Bohoudi; Miguel A Palacios
Journal:  Phys Imaging Radiat Oncol       Date:  2019-03-06

6.  Design and construction of a customizable phantom for the characterization of the three-dimensional magnetic resonance imaging geometric distortion.

Authors:  Tarraf Torfeh; Rabih Hammoud; Satheesh Paloor; Yoganathan Arunachalam; Souha Aouadi; Noora Al-Hammadi
Journal:  J Appl Clin Med Phys       Date:  2021-10-31       Impact factor: 2.102

7.  Delivery of Online Adaptive MRI-Guided Radiation Therapy for a Deaf Patient.

Authors:  Lauren C Linkowski; Austin J Sim; Gage Redler; Andrew S Brohl; Stephen A Rosenberg; Evan J Wuthrick
Journal:  Cureus       Date:  2022-08-01

8.  Implementation of a dedicated 1.5 T MR scanner for radiotherapy treatment planning featuring a novel high-channel coil setup for brain imaging in treatment position.

Authors:  Veit Mengling; Christoph Bert; Rosalind Perrin; Siti Masitho; Thomas Weissmann; Sina Mansoorian; Hadi Siavooshhaghighi; Rolf Janka; Sylvain Doussin; Melanie Habatsch; Rainer Fietkau; Florian Putz
Journal:  Strahlenther Onkol       Date:  2020-10-25       Impact factor: 3.621

9.  Evaluating differences in respiratory motion estimates during radiotherapy: a single planning 4DMRI versus daily 4DMRI.

Authors:  Duncan den Boer; Johannes K Veldman; Geertjan van Tienhoven; Arjan Bel; Zdenko van Kesteren
Journal:  Radiat Oncol       Date:  2021-09-26       Impact factor: 3.481

10.  Clinical utility of Gafchromic film in an MRI-guided linear accelerator.

Authors:  Ilma Xhaferllari; Joshua P Kim; Ruchira Liyanage; Chang Liu; Dongsu Du; Anthony Doemer; Indrin J Chetty; Ning Wen
Journal:  Radiat Oncol       Date:  2021-06-26       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.